Waikoloa, Hawaii - Phase III trials show etanercept (Enbrel, Amgen Inc. and Wyeth) has efficacy and safety for moderate to severe psoriasis.
Derm In The News: September 24-30
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Discovering Dermatology Times: September 2023 BCC Management Supplement
Understanding Eyebrow and Eyelash Hair Loss in Severe Alopecia Areata
2 Clarke Drive Cranbury, NJ 08512